Impact of antiretroviral and tuberculosis therapies on CD4 + and CD8 + HIV/M. tuberculosis-specific T-cell in co-infected subjects

Immunology Letters

Volumn 198, Issue , 2018, Pages 33-43

  Chiacchio, Teresa ^a   Petruccioli, Elisa ^a   Vanini, Valentina ^a   Cuzzi, Gilda ^a   La Manna, Marco Pio ^b   Orlando, Valentina ^b   Pinnetti, Carmela ^a   Sampaolesi, Alessandro ^a   Antinori, Andrea ^a   Caccamo, Nadia ^b   Goletti, Delia ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

ART; CD4 + T cells; CD8 + T cells; HIV; Tuberculosis; Tuberculosis therapy

Indexed keywords

ANTIRETROVIRUS AGENT; BACTERIAL ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; STAPHYLOCOCCUS ENTEROTOXIN B; TUBERCULOSTATIC AGENT; CYTOKINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ADULT; ANTIBIOTIC THERAPY; ANTIRETROVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT TUBERCULOSIS; MALE; MIXED INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TUBERCULOSIS CONTROL; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS; VIROLOGY;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COINFECTION; CYTOKINES; FEMALE; HIV ANTIGENS; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS;

EID: 85045377513     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2018.04.001     Document Type: Article

References (48)

1. Houben, R.M., Dodd, P.J., The global burden of latent tuberculosis infection: a Re-estimation using mathematical modelling. PLoS Med., 13, 2016, e1002152.
2. WHO, Global Tuberculosis Report 2017., 2017 www.who.int/tb/publications/global_report/en/.
3. Geldmacher, C., Zumla, A., Hoelscher, M., Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis. Curr. Opin. HIV AIDS 7 (2012), 268–275.
4. Abdool Karim, S.S., Churchyard, G.J., Karim, Q.A., Lawn, S.D., HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet 374 (2009), 921–933.
5. Petruccioli, E., Scriba, T.J., Petrone, L., Hatherill, M., Cirillo, D.M., Joosten, S.A., Ottenhoff, T.H., Denkinger, C.M., Goletti, D., Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur. Respir. J. 48 (2016), 1751–1763.
6. Petruccioli, T.J., Scriba, L., Petrone, M., Hatherill, D.M., Cirillo, S.A., Joosten, L.R., Codecasa, T.H., Ottenhoff, C.M., Long-lasting tuberculous pleurisy. Eur. Respir. J., 49, 2017, 10.1183/13993003.00356-2017 Print 2017 May.
7. Goletti, D., Weissman, D., Jackson, R.W., Collins, F., Kinter, A., Fauci, A.S., The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammatory cytokines. J. Infect. Dis. 177 (1998), 1332–1338.
8. Hoshino, Y., Nakata, K., Hoshino, S., Honda, Y., Tse, D.B., Shioda, T., Rom, W.N., Weiden, M., Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J. Exp. Med. 195 (2002), 495–505.
9. Stacey, A.R., Norris, P.J., Qin, L., Haygreen, E.A., Taylor, E., Heitman, J., Lebedeva, M., DeCamp, A., Li, D., Grove, D., Self, S.G., Borrow, P., Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83 (2009), 3719–3733.
10. Goletti, D., Weissman, D., Jackson, R.W., Graham, N.M., Vlahov, D., Klein, R.S., Munsiff, S.S., Ortona, L., Cauda, R., Fauci, A.S., Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J. Immunol. 157 (1996), 1271–1278.
11. Williams, B.G., Lima, V., Gouws, E., Modelling the impact of antiretroviral therapy on the epidemic of HIV. Curr. HIV Res. 9 (2011), 367–382.
12. Guihot, A., Bourgarit, A., Carcelain, G., Autran, B., Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus. Trends Immunol. 32 (2011), 131–137.
13. Corbeau, P., Reynes, J., Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection. Blood 117 (2011), 5582–5590.
14. Hsu, D.C., Kerr, S.J., Iampornsin, T., Pett, S.L., Avihingsanon, A., Thongpaeng, P., Zaunders, J.J., Ubolyam, S., Ananworanich, J., Kelleher, A.D., Cooper, D.A., Restoration of CMV-specific-CD4T cells with ART occurs early and is greater in those with more advanced immunodeficiency. PLoS One, 8, 2013, e77479.
15. Keane, N.M., Price, P., Lee, S., Almeida, C.A., Stone, S.F., James, I., French, M.A., Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy. HIV Med. 5 (2004), 407–414.
16. Burgess, K., Price, P., James, I.R., Stone, S.F., Keane, N.M., Lim, A.Y., Warmington, J.R., French, M.A., Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART. J. Clin. Immunol. 26 (2006), 160–167.
17. Sallusto, F., Lenig, D., Forster, R., Lipp, M., Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 (1999), 708–712.
18. Sallusto, F., Geginat, J., Lanzavecchia, A., Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22 (2004), 745–763.
19. Appay, V., van Lier, R.A., Sallusto, F., Roederer, M., Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73 (2008), 975–983.
20. Chiacchio, T., Petruccioli, E., Vanini, V., Cuzzi, G., Pinnetti, C., Sampaolesi, A., Antinori, A., Girardi, E., Goletti, D., Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. J. Infect. 69 (2014), 533–545.
21. Delogu, G., Vanini, V., Cuzzi, G., Chiacchio, T., De Maio, F., Battah, B., Pinnetti, C., Sampaolesi, A., Antinori, A., Goletti, D., Lack of response to HBHA in HIV-infected patients with latent tuberculosis infection. Scand. J. Immunol. 84 (2016), 344–352.
22. Chiacchio, T., Delogu, G., Vanini, V., Cuzzi, G., De Maio, F., Pinnetti, C., Sampaolesi, A., Antinori, A., Goletti, D., Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection. PLoS One, 12, 2017, e0183846.
23. Geldmacher, C., Ngwenyama, N., Schuetz, A., Petrovas, C., Reither, K., Heeregrave, E.J., Casazza, J.P., Ambrozak, D.R., Louder, M., Ampofo, W., Pollakis, G., Hill, B., Sanga, E., Saathoff, E., Maboko, L., Roederer, M., Paxton, W.A., Hoelscher, M., Koup, R.A., Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4T cells after HIV-1 infection. J. Exp. Med. 207 (2010), 2869–2881.
24. Sutherland, J.S., Young, J.M., Peterson, K.L., Sanneh, B., Whittle, H.C., Rowland-Jones, S.L., Adegbola, R.A., Jaye, A., Ota, M.O., Polyfunctional CD4(+) and CD8(+) T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment. J. Immunol. 184 (2010), 6537–6544.
25. Goletti, D., Petruccioli, E., Joosten, S.A., Ottenhoff, T.H., Tuberculosis biomarkers: from diagnosis to protection. Infect. Dis. Rep., 8, 2016, 6568.
26. Goletti, D., Lee, M.R., Wang, J.Y., Walter, N., Ottenhoff, T.H.M., Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease. Respirology, 2018.
27. Jambo, K.C., Banda, D.H., Afran, L., Kankwatira, A.M., Malamba, R.D., Allain, T.J., Gordon, S.B., Heyderman, R.S., Russell, D.G., Mwandumba, H.C., Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria. Am. J. Respir. Crit. Care Med. 190 (2014), 938–947.
28. Goletti, D., Sanduzzi, A., Delogu, G., Performance of the tuberculin skin test and interferon-gamma release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches. J. Rheumatol. Suppl. 91 (2014), 24–31.
29. Nahid, P., Dorman, S.E., Alipanah, N., Barry, P.M., Brozek, J.L., Cattamanchi, A., Chaisson, L.H., Chaisson, R.E., Daley, C.L., Grzemska, M., Higashi, J.M., Ho, C.S., Hopewell, P.C., Keshavjee, S.A., Lienhardt, C., Menzies, R., Merrifield, C., Narita, M., O'Brien, R., Peloquin, C.A., Raftery, A., Saukkonen, J., Schaaf, H.S., Sotgiu, G., Starke, J.R., Migliori, G.B., Vernon, A., Executive summary official american thoracic society/centers for disease control and prevention/infectious diseases society of america clinical practice guidelines: treatment of drug-Susceptible tuberculosis. Clin. Infect. Dis. 63 (2016), 853–867.
30. Day, C.L., Abrahams, D.A., Lerumo, L., Janse van Rensburg, E., Stone, L., O'rie, T., Pienaar, B., de Kock, M., Kaplan, G., Mahomed, H., Dheda, K., Hanekom, W.A., Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J. Immunol. 187 (2011), 2222–2232.
31. Riou, C., Tanko, R.F., Soares, A.P., Masson, L., Werner, L., Garrett, N.J., Samsunder, N., Abdool Karim, Q., Abdool Karim, S.S., Burgers, W.A., Restoration of CD4+ responses to copathogens in HIV-Infected individuals on antiretroviral therapy is dependent on t cell memory phenotype. J. Immunol. 195 (2015), 2273–2281.
32. Kassa, D., Gebremichael, G., Alemayehu, Y., Wolday, D., Messele, T., van Baarle, D., Virologic and immunologic outcome of HAART in Human Immunodeficiency Virus (HIV)-1 infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, Ethiopia, AIDS. Res. Ther., 10, 2013 (8-6405-10-18. eCollection 2013.
33. Schluger, N.W., Perez, D., Liu, Y.M., Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy. Chest 122 (2002), 597–602.
34. Day, C.L., Abrahams, D.A., Harris, L.D., van Rooyen, M., Stone, L., de Kock, M., Hanekom, W.A., HIV-1 infection is associated with depletion and functional impairment of mycobacterium tuberculosis-specific CD4T cells in individuals with latent tuberculosis infection. J. Immunol. 199 (2017), 2069–2080.
35. Rehr, M., Cahenzli, J., Haas, A., Price, D.A., Gostick, E., Huber, M., Karrer, U., Oxenius, A., Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J. Virol. 82 (2008), 3391–3404.
36. Axelsson-Robertson, R., Rao, M., Loxton, A.G., Walzl, G., Bates, M., Zumla, A., Maeurer, M., Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment. Int. J. Infect. Dis. 32 (2015), 23–29.
37. Nyendak, M.R., Park, B., Null, M.D., Baseke, J., Swarbrick, G., Mayanja-Kizza, H., Nsereko, M., Johnson, D.F., Gitta, P., Okwera, A., Goldberg, S., Bozeman, L., Johnson, J.L., Boom, W.H., Lewinsohn, D.A., Lewinsohn, D.M., Tuberculosis Research Unit and the Tuberculosis Trials Consortium, Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment. PLoS One, 8, 2013, e81564.
38. Petruccioli, E., Chiacchio, T., Pepponi, I., Vanini, V., Urso, R., Cuzzi, G., Barcellini, L., Cirillo, D., Palmieri, F., Ippolito, G., Goletti, D., First characterization of the CD4 and CD8 T-cell responses to quantiFERON-TB plus. J. Infect. 73 (2016), 588–597.
39. Kalokhe, A.S., Adekambi, T., Ibegbu, C.C., Ray, S.M., Day, C.L., Rengarajan, J., Impaired degranulation and proliferative capacity of Mycobacterium tuberculosis-specific CD8+ T cells in HIV-infected individuals with latent tuberculosis. J. Infect. Dis. 211 (2015), 635–640.
40. Saharia, K.K., Petrovas, C., Ferrando-Martinez, S., Leal, M., Luque, R., Ive, P., Luetkemeyer, A., Havlir, D., Koup, R.A., Tuberculosis therapy modifies the cytokine profile, maturation state, and expression of inhibitory molecules on mycobacterium tuberculosis-Specific CD4+ T-Cells. PLoS One, 11, 2016, e0158262.
41. Wilkinson, K.A., Seldon, R., Meintjes, G., Rangaka, M.X., Hanekom, W.A., Maartens, G., Wilkinson, R.J., Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 180 (2009), 674–683.
42. Geldmacher, C., Schuetz, A., Ngwenyama, N., Casazza, J.P., Sanga, E., Saathoff, E., Boehme, C., Geis, S., Maboko, L., Singh, M., Minja, F., Meyerhans, A., Koup, R.A., Hoelscher, M., Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J. Infect. Dis. 198 (2008), 1590–1598.
43. Connick, E., Lederman, M.M., Kotzin, B.L., Spritzler, J., Kuritzkes, D.R., St Clair, M., Sevin, A.D., Fox, L., Chiozzi, M.H., Leonard, J.M., Rousseau, F., D'Arc Roe, J., Martinez, A., Kessler, H., Landay, A., Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J. Infect. Dis. 181 (2000), 358–363.
44. Weinberg, A., Pahwa, S., Oyomopito, R., Carey, V.J., Zimmer, B., Mofenson, L., Kovacs, A., Burchett, S.K., Pediatric AIDS Clinical Trials Group 366 Team, Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin. Infect. Dis. 39 (2004), 107–114.
45. Puissant-Lubrano, B., Combadiere, B., Duffy, D., Wincker, N., Frachette, M.J., Ait-Mohand, H., Verrier, B., Katlama, C., Autran, B., Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients. Vaccine 27 (2009), 3576–3583.
46. Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C.M., Quigley, M.F., Almeida, J.R., Gostick, E., Yu, Z., Carpenito, C., Wang, E., Douek, D.C., Price, D.A., June, C.H., Marincola, F.M., Roederer, M., Restifo, N.P., A human memory T cell subset with stem cell-like properties. Nat. Med. 17 (2011), 1290–1297.
47. Lugli, E., Dominguez, M.H., Gattinoni, L., Chattopadhyay, P.K., Bolton, D.L., Song, K., Klatt, N.R., Brenchley, J.M., Vaccari, M., Gostick, E., Price, D.A., Waldmann, T.A., Restifo, N.P., Franchini, G., Roederer, M., Superior T memory stem cell persistence supports long-lived T cell memory. J. Clin. Invest. 123 (2013), 594–599.
48. Harari, A., Dutoit, V., Cellerai, C., Bart, P.A., Du Pasquier, R.A., Pantaleo, G., Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol. Rev. 211 (2006), 236–254.